Warren Buffett Retired Having Not Purchased His Favorite Stock -- a Company He Spent $78 Billion Buying Over 6 Years -- in 19 Months

Buffett was a net seller of equities for 13 consecutive quarters, disposing roughly $187 billion from Oct 1, 2022 to Dec 31, 2025, and previously spent about $78 billion repurchasing Berkshire shares from July 2018 to June 2024 but made no buybacks in the final 19 months before retiring. Berkshire's buyback policy change in July 2018 enabled repurchases when cash ≥ $30B and shares appeared cheap; during Buffett's active buyback period the stock traded at ~20–50% premium to book, rising to ~60–80% in the last 19 months. Successor Greg Abel restarted repurchases (announced Mar 5) with $373.3 billion in cash, cash equivalents and U.S. Treasuries on the balance sheet, and Class A shares trading near a 44% premium to book after a March 2 pullback, creating potential for opportunistic buybacks if valuation dislocates recur.

Analysis

A large, cash-rich conglomerate using opportunistic buybacks functions like an embedded market-maker for its own equity: repurchases add marginal bid liquidity when the market is weak and create asymmetric upside for patient holders without committing to recurring payouts. That optionality increases convexity in the share price — downside is capped by management stepping in, while upside benefits from normalization of multiples — and it shifts the marginal use of free cash away from dividends or smaller tuck‑ins toward price-support.

The immediate second-order beneficiaries are sectors that typically re-rate on valuation rotations (banks, energy, industrials): flows into a big buyback narrative tend to come out of high-multiple momentum tech names and redeploy into value/cash-generative businesses, tightening spreads for lenders and boosting cyclical cash flows. Market‑structure effects will show up in cheapening implied vol and put skew on the conglomerate’s options and in compressed liquidity for small-cap value as assets reallocate.

Primary risks are macro (a rapid rise in real rates that makes buybacks less accretive), governance or capital‑allocation shifts that divert cash to acquisitions, and a market rally that removes the “buy-the-dip” trigger — any of which would unwind the implied floor and create a sharp, multi‑week repricing. Watch short-term flows and insider/insurer reinsurance cash usage as early warning indicators; these lead price action by days-to-weeks.

Tactically, treat a buyback program as a binary catalyst: either it is maintained (supports a multi-month rerating) or it is monetized into M&A (different return profile). Position size for directional trades should be calibrated to a 3–12 month horizon and paired with volatility sells/hedges to monetize skew compression while capping downside from macro shocks.

Key Decisions for Investors

• Core long (BRKB) on confirmed continued repurchases: initiate a staggered position over 4 tranches if the stock underperforms the S&P 500 by >5% over 4 weeks or when a fresh 13D/13F/8-K confirms ongoing repurchases; horizon 3–12 months; target 12–25% downside-adjusted upside, stop-loss at 8% of notional or if buybacks stop.
• Pair trade—long BRKB / short SPY (equal dollar): allocate 1–2% of portfolio notional to capture a value rotation over 3–6 months; expected payoff 1.5–2x if market reweights to cash-generative names; hedge with a 3% tail put on the pair to protect against systemic sell-offs.
• Options play—buy a 9–12 month BRKB call debit spread sized to risk 0.5% of portfolio: sell a higher strike to finance and capture convexity from buyback-driven rerating while limiting max loss to the premium; target 2–3x return if repurchases persist and multiples expand.
• Sector reallocation—long OXY or CVX (6–12 months) vs short NVDA (or a small-cap tech momentum ETF): shift 2–3% notional from high-multiple momentum into energy/value to benefit from flows out of tech into cash-generative sectors; unwind if NVDA materially outperforms on secular catalysts or if rate volatility spikes above recent regime levels.